We have previously observed long-lived IgM responses following clinical P. vivax infections in a low transmission setting (Liu et al., 2022), and data on immune responses to P. falciparum indicate that IgM is a prominent feature of the antibody response to malaria, even in those with repeated infections over time (Boyle et al., 2019). The gene discussed is CD40LG; the disease is infection.